CLDX vs VNO · rev $37.0K vs rev $921.3M
Celldex Therapeutics Inc (CLDX) versus VNO (VNO) — a side-by-side from cached financials, not a winner call.
Celldex Therapeutics Inc (CLDX) is a biotechnology company listed on US.
VNO (VNO) common stock.
Latest reported CLDX revenue for 2026-06-30 was $37.0K. Net income was -$152.2M. CLDX currently screens at market cap $2.35B.
Latest reported VNO revenue for 2026-06-30 was $921.3M. Net income was $24.6M. VNO currently screens at market cap $0.
CLDX currently screens at market cap $2.35B. VNO currently screens at market cap $0.
Not investment advice. Open the CLDX and VNO stock pages for the full models.
Not investment advice.